Guerbet SA (LON:0ELV)

London flag London · Delayed Price · Currency is GBP · Price in EUR
26.70
+0.15 (0.56%)
At close: Feb 21, 2025
-12.58%
Market Cap 280.42M
Revenue (ttm) 712.83M
Net Income (ttm) 27.78M
Shares Out n/a
EPS (ttm) 2.20
PE Ratio 10.10
Forward PE n/a
Dividend 0.42 (1.59%)
Ex-Dividend Date Jul 1, 2024
Volume 410
Average Volume 53
Open 26.55
Previous Close 26.55
Day's Range 26.55 - 26.70
52-Week Range 15.70 - 32.50
Beta 0.78
RSI 52.00
Earnings Date Mar 26, 2025

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1926
Employees 2,920
Stock Exchange London Stock Exchange
Ticker Symbol 0ELV
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.